Co-authored by PATH’s Larry Slutsker, this article discusses a potential benefit of SP taken during pregnancy: preventing low birthweights. Formerly used only to prevent malaria, SP may still be relevant to healthy births, despite concerns of drug resistance.
This pilot explored the feasibility and utility of tracking the prevalence of malaria infection in pregnant women attending their first antenatal care (ANC) visit and infants presenting at 9–12 months of age for measles vaccination as possible sentinel populations to monitor changes in malaria prevalence.
Author: Benedictor E, Colaco R, Gutman J, Kafuko JM, Kaspar N, Mandike R, McElroy PD, Molteni F, Mugalura FE, Mutafungwa A, Mwaipape O, Ngondi JM, Ramsan MM, Reithinger R, Thadeo A, Willilo RA
Publication date: July 2016
Source: Malaria Journal